UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009325
Receipt number R000010827
Scientific Title Switch maintenance using UFT/LV therapy after Oxaliplatin based adjuvant chemotherapy for StageIII colorectal cancer
Date of disclosure of the study information 2012/11/13
Last modified on 2020/05/20 09:13:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Switch maintenance using UFT/LV therapy after Oxaliplatin based adjuvant chemotherapy for StageIII colorectal cancer

Acronym

FUTURE1202(SWIM III)

Scientific Title

Switch maintenance using UFT/LV therapy after Oxaliplatin based adjuvant chemotherapy for StageIII colorectal cancer

Scientific Title:Acronym

FUTURE1202(SWIM III)

Region

Japan


Condition

Condition

StageIII patients with curative resection for colorectal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the utility of Switch maitenance using UFT plus LV after Oxaliplatin based adjuvant chemotherapy for stageIII cololectal cancer with curative resection.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The complete rate of treatment, Safety

Key secondary outcomes

3year disease free survival time


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Within 8 weeks after Oxaliplatin based chemotherapy
(UFT/LV switch maintenance:5 course)
UFT/LV p.o(4 weeks on,1week off )
to be repeated every 5 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Patients with curative resection for
stageIII colorectal cancer.
2. Patients recieved Oxaliplatin based
chemotherapy as a prior therapy.
3. Possible patients using UFT/LV
maintenance therapy.
4. Age:20years to 80years
5. Performance Status:0-1
6. Patients sighed informed consent
7. Vital organ functions are preserved
within 14days prior to entry

Key exclusion criteria

1.Prior severe drug allergy
2.Nursing or pregnant females, or females
or mailes with partners who are
planning pregnancy
3.Presence of active infection
4.Serious complications
5.Inadequate cases for study enrollment
by the physician

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Yoichiro
Middle name
Last name Yoshida

Organization

Fukuoka University Faculty of Medicine

Division name

Department of Gastroenterological Surgery

Zip code

8140180

Address

7-45-1,Nanakuma,Johnan-ku,Fukuoka,814-0180,Japan

TEL

+928011011

Email

yyoshida@fukuoka-u.ac.jp


Public contact

Name of contact person

1st name Yoichiro
Middle name
Last name Yoshida

Organization

Fukuoka University Faculty of Medicine

Division name

Department of Gastroenterological Surgery

Zip code

8140180

Address

7-45-1,Nanakuma,Johnan-ku,Fukuoka,814-0180,Japan

TEL

0928011011

Homepage URL


Email

yyoshida@fukuoka-u.ac.jp


Sponsor or person

Institute

Fukuoka Tumor Research(FUTURE)

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukuoka Univesity

Address

7-45-1 Nanakuma, Jonan-ju

Tel

0928011011

Email

yyoshida@fukuoka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

福岡大学医学部消化器外科学


Other administrative information

Date of disclosure of the study information

2012 Year 11 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 09 Month 01 Day

Date of IRB

2012 Year 09 Month 01 Day

Anticipated trial start date

2012 Year 11 Month 05 Day

Last follow-up date

2019 Year 01 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 11 Month 13 Day

Last modified on

2020 Year 05 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010827


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name